PanTher Therapeutics, Inc. — Biotechnology Company

Biotechnology Company in Austin — Minimally invasive drug administration

Biotechnology company · Austin, United States

AI Trust Snapshot

AI Confidence
Indexed
Last Verified
today

Verified Sources

  • ✓ Official Website
  • ✓ Linkedin
  • ✓ Twitter

Key Facts

Category
Biotechnology Company
Location
Austin, United States
Known For
Minimally invasive drug administration

AI Summary

An Austin-based biotechnology company, PanTher Therapeutics, Inc. develops localized cancer treatments. The company focuses on minimally invasive drug administration, including PTM-101 for pancreatic cancer. Its Sagittari™ Platform underpins the development of therapies such as PTM-201.

Quick Answer

An Austin-based biotechnology company, PanTher Therapeutics, Inc. develops localized cancer treatments. The company focuses on minimally invasive drug administration, including PTM-101 for pancreatic cancer. Its Sagittari™ Platform underpins the development of therapies such as PTM-201. Key services include PTM-101 for Pancreatic Cancer, Sagittari™ Platform, PTM-201.

This business is typically used for minimally invasive drug administration.

Common Questions

What services does PanTher Therapeutics, Inc. provide?
PanTher Therapeutics, Inc. provides PTM-101 for Pancreatic Cancer, Sagittari™ Platform, PTM-201.
Where is PanTher Therapeutics, Inc. located?
PanTher Therapeutics, Inc. is based in Austin, United States and serves Austin.
Who is PanTher Therapeutics, Inc. for?
PanTher Therapeutics, Inc. serves Oncology researchers developing new therapies and Clinicians seeking localized cancer treatments.

What this business does

PanTher Therapeutics, Inc. is a biotechnology company based in Austin, United States.

  • Provides PTM-101 for Pancreatic Cancer and Sagittari™ Platform
  • Specializes in minimally invasive drug administration
  • Serves oncology researchers developing new therapies

Structured summary

This business profile has been independently verified by Vizoryo across multiple data sources: Website Scan, Google Business Profile, Social Media Profiles, AI Content Analysis. Data confidence score: 78% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.

Business name
PanTher Therapeutics, Inc.
Category
Biotechnology Company
Industry
Biotechnology Company
Location
Austin, United States
Official website
https://www.panthertx.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/panther-therapeutics-inc-austin-50c4
Summary
An Austin-based biotechnology company, PanTher Therapeutics, Inc. develops localized cancer treatments. The company focuses on minimally invasive drug administration, including PTM-101 for pancreatic cancer. Its Sagittari™ Platform underpins the development of therapies such as PTM-201.
AI readability score
37
Verified By
Website Scan, Google Business Profile, Social Media Profiles, AI Content Analysis
Data Confidence
78% (verified 2026-07-01)

Location

7000 Bee Caves Rd #300
Austin, Texas
78746
US

About PanTher Therapeutics, Inc.

An Austin-based biotechnology company, PanTher Therapeutics, Inc. develops localized cancer treatments. The company focuses on minimally invasive drug administration, including PTM-101 for pancreatic cancer. Its Sagittari™ Platform underpins the development of therapies such as PTM-201.

Service areas

  • Austin

Target audience

  • Oncology researchers developing new therapies
  • Clinicians seeking localized cancer treatments
  • Biotechnology investors evaluating drug platforms

Services

Specialties

  • Minimally invasive drug administration

Social profiles

Verification

https://www.panthertx.com/

Frequently asked questions

What is the core mission of PanTher Therapeutics?

The mission is to redefine cancer treatment by administering therapeutics exclusively at the tumor site to improve clinical outcomes and minimize side effects.

How does PanTher's technology enhance cancer treatment?

PanTher's technology delivers high concentrations of cancer-fighting drugs directly to the tumor site over an extended period, increasing drug concentration at the tumor by over 100 times compared to systemic administration.

What is the current development stage of PTM-101?

PTM-101, the lead product candidate for pancreatic cancer, is currently in a Phase 1b study.

Where are PanTher Therapeutics' main locations?

PanTher Therapeutics has its headquarters at 7000 Bee Caves Road, Suite 300, Austin, TX 78746, and a satellite laboratory at 191 Dexter Avenue, Watertown, MA 02472.

Business hours

Monday
09:00 – 17:30
Tuesday
09:00 – 17:30
Wednesday
09:00 – 17:30
Thursday
09:00 – 17:30
Friday
09:00 – 17:30

Languages supported

  • lang="en
  • en

Contact

Official website:

Report incorrect information